Stempeutics partners with Cipla for its stem cell drug – Economic Times
Economic TimesStempeutics partners with Cipla for its stem cell drugEconomic TimesNEW DELHI: Biotech firm Stempeutics Research today said it has inked an out-licensing deal with drug major Cipla for its stem cell therapy product Stempeucel, indicated f… Continue reading
